Author

Konstantinos Venetis

Observed names: K. Venetis, VENETIS, KONSTANTINOS, Venetis, Konstantinos
ORCID: 0000-0002-0163-879X
Observed ORCID: 0000-0002-0163-879X
OpenAlex ID: A5003154349
2022 · Konstantinos Venetis, Edoardo Crimini, et al. · Frontiers in Molecular Biosciences · 161
2023 · Mariia Ivanova, Francesca Maria Porta, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 128
2021 · Konstantinos Venetis, Roberto Piciotti, et al. · Cells · 114
2022 · Chiara Corti, Konstantinos Venetis, et al. · Expert Opinion on Investigational Drugs · 92
2020 · Marco Invernizzi, Alessandro de Sire, et al. · Frontiers in Oncology · 87
2023 · Konstantinos Venetis, Francesco Pepe, et al. · Cancer Treatment Reviews · 75
2025 · Nicola Fusco, Konstantinos Venetis, et al. · The Journal of Liquid Biopsy · 74
2019 · Fabio Pagni, Elena Guerini-Rocco, et al. · International Journal of Molecular Sciences · 64
2021 · Elham Sajjadi, Konstantinos Venetis, et al. · Cancer Cell International · 54
2025 · Roberto Borea, Erick F. Saldanha, et al. · Critical Reviews in Oncology/Hematology · 46
2022 · Elham Sajjadi, Konstantinos Venetis, et al. · Cancer Drug Resistance · 45
2023 · Konstantinos Venetis, Giulia Cursano, et al. · The Journal of Liquid Biopsy · 44
2023 · Elham Sajjadi, Elena Guerini-Rocco, et al. · Frontiers in Molecular Biosciences · 44
2020 · Elham Sajjadi, Konstantinos Venetis, et al. · ecancermedicalscience · 43
2020 · Konstantinos Venetis, Marco Invernizzi, et al. · Cancer Treatment Reviews · 43
2020 · Gianluca Lopez, Marianna Noale, et al. · International Journal of Molecular Sciences · 42
2021 · Carmen Criscitiello, Elena Guerini-Rocco, et al. · Anti-Cancer Agents in Medicinal Chemistry · 40
2023 · Mariia Ivanova, Francesca Maria Porta, et al. · Genes · 38
2023 · Francesco Pepe, Elena Guerini-Rocco, et al. · Journal of Clinical Pathology · 37
2022 · Nicola Fusco, Elham Sajjadi, et al. · Critical Reviews in Oncology/Hematology · 36
Works count: 138
Citation count: 2,753
H-index: 31
I10-index: 63
Year
Topic
Type